Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Anastasia Coldren"'
Autor:
MARCELA BRISSOVA, HEATHER H. DURAI, SHAOJUN MEI, ANASTASIA COLDREN, COREY DAVIS, CONRAD REIHSMANN, ALEXANDER L. HOPKIRK, DANNIELLE GIBSON, RADHIKA ARAMANDLA, GREG POFFENBERGER, DIANE C. SAUNDERS, ALVIN C. POWERS, JOYCE C. NILAND, CARMELLA EVANS-MOLINA
Publikováno v:
Diabetes. 71
The Integrated Islet Distribution Program (IIDP) is currently the largest source of human islets for research in the U.S. The IIDP Human Islet Phenotyping Program (HIPP) provides standardized islet assessment and makes these data available to researc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41e4ee6ead89a24b7c577d918b8ceb78
https://doi.org/10.2337/db22-255-lb
https://doi.org/10.2337/db22-255-lb
Autor:
Appakalai N. Balamurugan, Yan Li, Chen Huang, Guoqiang Gu, Chen Weng, Irina Kaverina, Yanwen Xu, Xiaodun Yang, Marcela Brissova, Emily M. Walker, Roland Stein, Gillian E. Erickson, Ruiying Hu, Christopher V.E. Wright, Anastasia Coldren
Publikováno v:
Dev Cell
Although cellular stress response is important for maintaining function and survival, overactivation of late-stage stress effectors cause dysfunction and death. We show that the myelin transcription factors (TFs) Myt1 (Nzf2), Myt2 (Myt1l, Nztf1, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::abf364d5fcea03d6e34dad07268fd2d2
https://doi.org/10.1016/j.devcel.2020.04.003
https://doi.org/10.1016/j.devcel.2020.04.003
Autor:
Kellie D, Nance, Emily L, Days, C David, Weaver, Anastasia, Coldren, Tiffany D, Farmer, Hyekyung P, Cho, Colleen M, Niswender, Anna L, Blobaum, Kevin D, Niswender, Craig W, Lindsley
Publikováno v:
Journal of medicinal chemistry. 60(4)
A duplexed, functional multiaddition high throughput screen and subsequent optimization effort identified the first orally bioavailable and CNS penetrant glucagon-like peptide-1 receptor (GLP-1R) noncompetitive antagonist. Antagonist 5d not only bloc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::56f7ce040a3b8e5ccd6a9c696bc21471
https://pubmed.ncbi.nlm.nih.gov/28103022
https://pubmed.ncbi.nlm.nih.gov/28103022
Autor:
Shawn Levy, Scott Wisniewski, Greg Poffenberger, Jason M. Spaeth, Anastasia Coldren, Alena Shostak, Kristie Aamodt, Roland Stein, Hai Yan, Christopher B. Newgard, Nadejda Bozadjieva, Kasey C. Vickers, Mingyu Li, Alison Von Deylen, Anthony Botros, Wenbiao Chen, Nripesh Prasad, Lisette A. Maddison, Olga Ilkayeva, Chunhua Dai, Neil Phillips, Jackie D Corbin, Leslie R Sedgeman, Ernesto Bernal-Mizrachi, Michael C Semich, E. Danielle Dean, Alvin C. Powers, Wei Gu
Publikováno v:
Cell metabolism. 25(6)
Decreasing glucagon action lowers the blood glucose and may be useful therapeutically for diabetes. However, interrupted glucagon signaling leads to α-cell proliferation. To identify postulated hepatic-derived, circulating factor(s) responsible for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3c578e695559604fdc30d244e8a55eab
https://pubmed.ncbi.nlm.nih.gov/28591638
https://pubmed.ncbi.nlm.nih.gov/28591638